
Nephros CEO Robert Banks said the water safety market is expanding beyond legionella to include PFAS, biofilm and nanoplastics, widening the company's addressable opportunity.
Nephros CEO Robert Banks told an investor event Tuesday that the water safety market is expanding beyond the traditional focus on legionella, creating a wider addressable opportunity for the filtration company.
"Just a few years ago, most conversations centered around legionella," Banks said. "Today, the discussion is much broader."
Customers are now asking about opportunistic premise plumbing pathogens, biofilm, antibiotic-resistant organisms, PFAS, lead, aging infrastructure and micro- and nanoplastics, he said.
Banks framed the shift as a structural change for Nephros, which sells water purification systems to hospitals, dialysis clinics, commercial buildings, laboratories and food-service operations. The company's pitch is that water-quality failures can shut down buildings, damage equipment and erode patient trust.
"Today's event isn't really about filters, it's about water," he said.
Nephros shares trade thinly on the OTC market. The company has been working to expand beyond its core hospital filtration business into broader commercial and institutional settings, where water-safety regulations are tightening in several U.S. states.
CFO Judy Krandel also spoke at the event, which was webcast Tuesday afternoon. The company has not yet provided updated financial guidance for the current quarter.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.